Category: Science / Technology

Campaigners bid to tackle cancer

… a special virtual reality headset at the event yesterday. Event host Councillor Eddie Moores, cabinet member for health and wellbeing, said: “Oldham Council was really pleased to support this event for staff and to help raise awareness about cancer …

First stem cell study could lead to development of therapy to reduce inflammation caused by CF

A 39-year-old man with cystic fibrosis made history by becoming the first person to receive human adult stem cells in a new research study that researchers hope will someday lead to the development of a therapy to reduce the inflammation and infection caused by CF. The pioneering subject in the study is Bob Held from Alliance, Ohio, who on Jan. 26 received an infusion of cells called allogeneic human mesenchymal stem cells , adult stem cells collected from the bone marrow of healthy volunteers.

3 Biotech Stocks I’d Buy Right Now

Despite the sway of political uncertainty for the biotechnology industry at the moment, these three stocks look like great buys right now. Conflicting statements from the Trump administration have made owning biotech stocks feel like a roller-coaster ride in recent weeks, but there are a few stocks I’d happily buy and hold despite the sway of political uncertainty.

Islets from rat-grown mouse pancreases can help reverse disease in diabetic mice

Mouse pancreases grown in rats generate functional, insulin-producing cells that can reverse diabetes when transplanted into mice with the disease, according to researchers at the Stanford University School of Medicine and the Institute of Medical Science at the University of Tokyo. The recipient animals required only days of immunosuppressive therapy to prevent rejection of the genetically matched rather than lifelong treatment.

Islets from rat-grown mouse pancreases can help reverse disease in diabetic mice

Mouse pancreases grown in rats generate functional, insulin-producing cells that can reverse diabetes when transplanted into mice with the disease, according to researchers at the Stanford University School of Medicine and the Institute of Medical Science at the University of Tokyo. The recipient animals required only days of immunosuppressive therapy to prevent rejection of the genetically matched rather than lifelong treatment.

Scientist Alan Mackay-Sim is Australian of the Year 2017

Australian of the Year 2017 is Alan Mackay-Sim: Scientist whose stem cell research is helping to repair damaged spinal cords wins national award Biomedical scientist Alan Mackay-Sim, whose research has been hailed ‘more impressive than man walking on the moon’, has been named the 2017 Australian of the Year. The Queensland-based professor has dedicated his life to pioneering stem cell research and its use in repairing damaged spinal cords, including helping to restore mobility in a quadriplegic man.

OHSU’s HIV vaccine technology acquired by Bay Area biotech

A San Francisco-based biotech company has acquired vaccine research by Oregon Health & Science University scientists, marking a critical step toward commercialization of a promising HIV vaccine. The deal involves the startup Vir Biotechnology Inc. buying TomegaVax Inc., an OHSU spinoff that holds the rights to the vaccine technology developed by Dr. Louis Picker and Klaus Frueh at OHSU’s Vaccine and Gene Therapy Institute in Beaverton.

Study finds cutting calories may help monkeys live longer

A 2009 image of rhesus monkeys in a landmark study of the benefits of caloric restriction. The then 27-year-old monkey on the left was given a diet with fewer calories while the 29-year-old monkey on the right was allowed to eat as much as it liked.A new study of the effects of a restricted diet reinforces the idea that reducing caloric intake has health benefits that can extend lifespan.

Meet the soft robot which keeps your heart beating

A soft robot which embraces failing hearts to keep blood pumping could one day be used to help keep people with heart failure alive. Developed by researchers from the Massachusetts Institute of Technology and described last week in the academic journal Science Translational Medicine , the robotic sleeve was created to mimic the composition of human heart tissue.

Cell-Free Embryonic Stem Cell Extract-Mediated Derivation of…

The oocyte-independent source for the generation of pluripotent stem cells is among the ultimate goals in regenerative medicine. We report that on exposure to mouse embryonic stem cell extracts, reversibly permeabilized NIH3T3 cells undergo dedifferentiation followed by stimulus-induced redifferentiation into multiple lineage cell types.

Soft Robot Helps the Heart Beat

Harvard University and Boston Children’s Hospital researchers have developed a customizable soft robot that fits around a heart and helps it beat, potentially opening new treatment options for people suffering from heart failure. The soft robotic sleeve twists and compresses in synch with a beating heart, augmenting cardiovascular functions weakened by heart failure.

A Warning to Trump From Friedrich Hayek

If American conservatives have an intellectual hero, it might well be Friedrich Hayek — and rightly so. More clearly than anyone else, Hayek elaborated the case against government planning and collectivism, and mounted a vigorous argument for free markets.

Flood of News Presents Buying Opportunity

… 5 million and 6 million patients. Beyond the FDA, word just came in from the Paul Ehrlich Institute, Germany’s health regulator, that the same trial could begin enrollment there. Though the trial will be enrolling 250 patients globally, approval is …

Introducing Centrelink’s robo-public servant

Public servants could find themselves replaced with robots sooner than anyone expected with Centrelink soon to step up experiments with “virtual” welfare officers manning the agency’s shopfronts around Australia. Centrelink will soon have two robo-assistants answering questions from the public, one of them about the National Disability Insurance Scheme, the other helping young people with the complexities of claiming student benefits.

Cellect Receives Patent Notice of Allowance from US Patent &…

Cellect Biotechnology Ltd. , a developer of stem cells isolation technology, announces today that it has received a formal notice of allowance around a key method of treatment patent from the United States Patent & Trademark Office. The allowed claims relate to the engineering of regulatory immune cells with enhanced apoptotic activity to be used for immunomodulation for treating or preventing immune related disorders.

Research suggests the stem cells in our teeth can be energized to fill in chips, cracks, and cavities

The stem cells in our teeth can be energized to fill in chips, cracks, and cavities, researchers say, and the findings could one day possibly make dental cement obsolete. The work has been conducted just in mice so far, but the research , published Monday in the journal Scientific Reports, highlights a way to motivate stem cells to repair tooth defects at a scale they normally can’t, with a drug that already has some safety testing behind it.

All my children call the centre ‘Our Maggie’s’

But last year the father-of-five discovered that he is also one in 500, after being diagnosed with a rare blood cancer called mantle cell lymphoma. Before his diagnosis in November, Andrew was the fittest he had been in years, after giving up booze and losing three stone through his passion for cycling.

Postdoctoral Fellow Positions Available

Postdoctoral fellow positions in neuroscience are available at the Department of Neurosurgery in the State University of New York Upstate Medical University in the . We are looking for highly motivated postdocs with experience in both in vivo and in vitro to join our research team for performing US federal government funded research projects.

Number of shares and votes in Active Biotech

Today, the last trading day of the month, there are in total 96,824,320 shares and votes in Active Biotech. For further information, please contact: Tomas Leanderson, CEO Tel: +46 46 19 20 95 E-mail: tomas.leanderson@activebiotech.com Active Biotech AB is a biotechnology company with focus on neurodegenerative/inflammatory diseases and cancer.